Results 61 to 70 of about 54,964,175 (374)

Pazopanib Combined With Vincristine and Irinotecan in Relapsed Wilms Tumor: Encouraging Outcomes in a Heavily Pretreated Pediatric Cohort

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background While Wilms tumor (WT) typically has a favorable prognosis, relapsed cases—especially those with high‐risk histology—remain therapeutically challenging after intensive frontline therapy. The combination of vincristine and irinotecan has demonstrated activity in pediatric solid tumors, and pazopanib, a multi‐targeted tyrosine kinase ...
Maria Debora De Pasquale   +6 more
wiley   +1 more source

2012 Annual Report [PDF]

open access: yes, 2012
https://nsuworks.nova.edu/arsh_annualreport/1001/thumbnail ...
Center for Applied Research on Substance Use and Health Disparities
core   +1 more source

Personalizing the Pediatric Hematology/Oncology Fellowship: Adapting Training for the Next Generation

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT The pediatric hematology‐oncology fellowship training curriculum has not substantially changed since its inception. The first year of training is clinically focused, and the second and third years are devoted to scholarship. However, this current structure leaves many fellows less competitive in the current job market, resulting in ...
Scott C. Borinstein   +3 more
wiley   +1 more source

Lessons from the National institutes of health innovation corps program: defining barriers to developing and commercializing novel solutions for persons with opioid use disorder

open access: yesAddiction Science & Clinical Practice
Background Translating innovative research advancements into commercially viable medical interventions presents well-known challenges. However, there is limited understanding of how specific patient, clinical, social, and legal complexities have further ...
Matthew P. Heshmatipour   +9 more
doaj   +1 more source

Doing community-based research during dual public health emergencies (COVID and overdose)

open access: yesHarm Reduction Journal, 2023
Meaningful engagement and partnerships with people who use drugs are essential to conducting research that is relevant and impactful in supporting desired outcomes of drug consumption as well as reducing drug-related harms of overdose and COVID-19 ...
Phoenix Beck McGreevy   +16 more
doaj   +1 more source

2014 Annual Report [PDF]

open access: yes, 2014
https://nsuworks.nova.edu/arsh_annualreport/1003/thumbnail ...
Center for Applied Research on Substance Use and Health Disparities
core   +1 more source

Psychosocial Outcomes in Patients With Endocrine Tumor Syndromes: A Systematic Review

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Introduction The combination of disease manifestations, the familial burden, and varying penetrance of endocrine tumor syndromes (ETSs) is unique. This review aimed to portray and summarize available data on psychosocial outcomes in patients with ETSs and explore gaps and opportunities for future research and care.
Daniël Zwerus   +6 more
wiley   +1 more source

Denial of prescription pain medication among people who use drugs in Vancouver, Canada

open access: yesHarm Reduction Journal
Background People who use drugs experience pain at two to three times the rate of the general population and yet continue to face substantial barriers to accessing appropriate and adequate treatment for pain.
Evelyne Marie Piret   +6 more
doaj   +1 more source

Injecting drugs alone during an overdose crisis in Vancouver, Canada

open access: yesHarm Reduction Journal, 2022
Background Settings throughout Canada and the USA continue to experience crises of overdose death due to the toxic unregulated drug supply. Injecting drugs alone limits the potential for intervention and has accounted for a significant proportion of ...
Alexa Norton   +5 more
doaj   +1 more source

2011 Annual Report [PDF]

open access: yes, 2011
https://nsuworks.nova.edu/arsh_annualreport/1000/thumbnail ...
Center for Applied Research on Substance Use and Health Disparities
core   +1 more source

Home - About - Disclaimer - Privacy